Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest Pain
View Full PaperWhy the trial?
Patients whose acute chest pain proves not to be myocardial infarction still carry meaningful longer-term coronary risk. TARGET-CTCA asked whether early outpatient CT coronary angiography after MI has been ruled out prevents subsequent infarction or cardiovascular death.
Does outpatient CT coronary angiography-guided care reduce the composite of myocardial infarction or death from a cardiac cause in patients with suspected acute coronary syndrome in whom myocardial infarction has been ruled out and who have intermediate risk?
Population
3,170 intermediate-risk patients (hs-cTn >5 ng/L) with MI ruled out, 14 UK hospitals
Comparison
Outpatient CT coronary angiography-guided care vs standard care
Design
Multicenter randomized controlled trial (1:1); blinding not described
Follow-up
Median 3.0 years
Key result
Routine CT coronary angiography-guided management did not reduce the incidence of myocardial infarction or cardiac death compared to standard care (HR 0.95; 95% CI 0.73-1.23; P=0.71).
Authors
Experts read TARGET-CTCA as a clear null result, reinforcing that routine CT coronary angiography after a heart attack has been ruled out does not improve outcomes and should not be adopted into practice.
Cardiologists view this trial as strong evidence against adding routine coronary CT scanning for patients whose troponin results leave them in an intermediate-risk zone once a heart attack has been excluded. The reaction is broadly one-sided, with no expert arguing the imaging strategy should still be pursued. The live question is whether these findings will prompt guideline bodies to narrow the indications for outpatient CTCA in acute chest pain pathways.
Multiple experts agree that routine CTCA after myocardial infarction has been ruled out does not improve patient outcomes and is not warranted.
What they’re arguing about
supportiveneutralcautiouscritical
Counts are expert takes we classified by axis. Tap a row to see the takes behind its count.
It remains uncertain whether specific subgroups within the intermediate-risk troponin population might still benefit from CTCA, and whether guidelines will now formally narrow the indications for outpatient CTCA in acute chest pain pathways.
Damluji sees TARGET-CTCA as confirming a broader principle: blanket application of a test to all comers rarely produces benefit. He highlights the trial design as rigorous but the result as unsurprising given prior evidence.
Mills, the trial presenter, states the findings provide strong evidence that patients who have had a heart attack excluded do not benefit from early outpatient CTCA. He argues clinicians can reassure these patients that their future risk is low.
Routine early CTCA adds no benefit after MI exclusion; confirms standard care alone suffices for event reduction in this population.
| Outcome | CTCA-guided | Standard care |
|---|---|---|
| MI or death from a cardiac cause | 112/1,587 (7.1%) | 116/1,583 (7.3%) |
| Adjusted HR 0.95 (95% CI 0.73-1.23; P=0.71) · no benefit; treatment separation was good (CTCA in 92.1% vs 2.2%) | ||
Patient burden
CTCA-related adverse events 7/1,587 (0.4%) in the CTCA group.
Representation
applies only to intermediate-risk patients (peak hs-cTn >5 ng/L) after MI has been ruled out, and was conducted entirely in the UK (14 hospitals).
Design limitations
follow-up was event-driven, ending once standard-care primary-outcome events exceeded the prespecified minimum of 97.
Does outpatient CT coronary angiography-guided care reduce the composite of myocardial infarction or death from a cardiac cause in patients with suspected acute coronary syndrome in whom myocardial infarction has been ruled out and who have intermediate risk?
Routine outpatient CT coronary angiography-guided management did not reduce the incidence of subsequent myocardial infarction or cardiac death compared to standard care in patients with suspected ACS and intermediate risk after MI rule-out.
Hazard Ratio: 0.95 (95% CI 0.73–1.23)
Absolute Event Rate: 7.1% vs 7.3%
p-value: p=0.71
Journal, society, and media accounts. Useful signal, not independent expert judgment.
Lee et al. (2026) conducted an RCT in Suspected acute coronary syndrome (n=3,170). CT coronary angiography-guided care vs. Standard care was evaluated on Composite of myocardial infarction or death from a cardiac cause (HR 0.95, 95% CI 0.73 to 1.23, p=0.71). Routine CT coronary angiography-guided management did not reduce the incidence of myocardial infarction or cardiac death compared to standard care (HR 0.95; 95% CI 0.73-1.23; P=0.71).